Website & contact details
- Website
Lightox Limited
- Incorporated
- 2 August 2016 (10 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Carrie Ann Ambler
- Accounts type
- Total exemption full
- Region
- North West
- Address
- C/o Menzies LLP One Express1 George Leigh StreetManchesterM4 5DL
Filing status
- Accounts due
- 31 May 2027
- Last accounts
- 31 August 2025
- Conf. stmt due
- 15 August 2027
- Last conf. stmt
- 1 August 2026
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
British
Born March 1983 (43)
Director · Appointed 10 January 2018
British
Born October 1979 (47)
Ambler, Carrie Ann, Dr
Director · Appointed 17 March 2017
British
Born June 1975 (51)
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (2)
3 May 2024
Ceased High Force Research Limited — Owns 25–50% of shares
27 June 2017
Ceased Andrew Whiting — Owns 75–100% of shares
Financials
Balance sheet as at 31 August 2025 · total exemption full accounts
- Net Assets
- £73,333
- Cash
- £75,837
- Employees
- 15
- Debt Ratio
- 61%
- Current Ratio
- 1.3x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fixed Assets | £37,578 | £25,360 | £44,915 | £70,609 | £22,919 | £21,423 | £17,108 |
| Current Assets | £152,385 | £520,447 | £165,832 | £211,143 | £718,688 | £462,889 | £249,144 |
| Debtors | £413,503 | £115,450 | £164,045 | £112,863 | £237,835 | £98,500 | |
| Cash | £75,837 | £71,944 | £15,382 | £12,098 | £570,825 | £225,054 | £150,644 |
| Creditors (< 1 year) | £116,630 | £85,650 | £2,733,077 | £2,093,300 | £1,631,155 | £716,316 | £7,397 |
| Creditors (> 1 year) | £16,886 | ||||||
| Net Current Assets | £35,755 | £434,797 | (£2,567,245) | (£1,882,157) | (£912,467) | (£253,427) | £241,747 |
| Net Assets | £73,333 | £443,271 | |||||
| Shareholder Funds | £443,271 | (£2,522,330) | (£1,811,548) | (£889,548) | (£232,004) | £258,855 |
What Lightox say about themselves
“Illuminating therapeutics & research tools. LightOx are developing new therapeutic solutions to improve patient’s function and long-term outcomes with oral cancer. We have a unique range of molecular tools for use in imaging, therapeutics and assay development.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 14 August 2026 | Confirmation statement with updates | 1 August 2026 | ||
| 21 July 2026 | Termination of appointment of a director | |||
| 21 July 2026 | Termination of appointment of a director | |||
| 30 April 2026 | Total exemption full accounts | 31 August 2025 | ||
| 6 March 2026 | Statement of capital following an allotment of shares |
Some other companies at this address
Other companies in this industry
Didcot
London
Sandwich
Melbourn
London
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →